Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction

• Martin Negreira-Caamaño,
• Jorge Martínez-Del Río,
• Alfonso Morón-Alguacil,
• Pedro Pérez-Díaz,
• Jesus Piqueras-Flores

Affiliations

Martin Negreira-Caamaño

Cardiology Department, University General Hospital of Ciudad Real, Spain

Jorge Martínez-Del Río

Cardiology Department, University General Hospital of Ciudad Real, Spain

Alfonso Morón-Alguacil

Cardiology Department, University General Hospital of Ciudad Real, Spain

Pedro Pérez-Díaz

Cardiology Department, University General Hospital of Ciudad Real, Spain; Cardiomyopathies and Inherited Disease Unit, Cardiology Department, University General Hospital of Ciudad Real, Spain

Jesus Piqueras-Flores

Cardiology Department, University General Hospital of Ciudad Real, Spain; Cardiomyopathies and Inherited Disease Unit, Cardiology Department, University General Hospital of Ciudad Real, Spain; Medicine Faculty, Castilla La-Mancha University, Ciudad Real, Spain; Corresponding author.